{"altmetric_id":2683620,"counts":{"readers":{"mendeley":9,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["561052004009640"],"posts_count":1},"total":{"posts_count":3},"twitter":{"unique_users_count":2,"unique_users":["inbraced","Hakase_Taro"],"posts_count":2}},"selected_quotes":["Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18 from Children's Hospital of Philadelphia."],"citation":{"abstract":"Ch14.18 improves survival in children with high-risk neuroblastoma but is associated with substantial toxicity. Ch14.18 pharmacokinetics were previously reported to be highly variable and characterized by a higher clearance in children than in adults, and a large volume of distribution. Identifying factors responsible for its variability could lead to alternative dosing strategies that reduce toxicity.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e93cf058f610002497","authors":["Desai AV","Fox E","Smith LM","Lim AP","Maris JM","Balis FM"],"doi":"10.1007\/s00280-014-2575-9","first_seen_on":"2014-09-15T08:37:55+00:00","funders":["niehs"],"issns":["0344-5704"],"issue":"","journal":"Cancer Chemotherapy & Pharmacology","last_mentioned_on":1416314133,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25212536?dopt=Abstract","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25212536#"],"pmid":"25212536","pubdate":"2014-09-13T00:00:00+00:00","publisher_subjects":[{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Life Sciences","Medicine","Health Sciences","Pharmacology, Toxicology and Pharmaceutics","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms","antineoplasticagents"],"title":"Pharmacokinetics of the chimeric anti-G<sub>D2<\/sub> antibody, ch14.18, in children with high-risk neuroblastoma.","type":"article","volume":"","mendeley_url":"http:\/\/www.mendeley.com\/research\/pharmacokinetics-chimeric-antigd2-antibody-ch1418-children-highrisk-neuroblastoma"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":4522755,"mean":5.2848280542506,"rank":2320977,"this_scored_higher_than_pct":35,"this_scored_higher_than":1606023,"rank_type":"exact","sample_size":4522755,"percentile":35},"similar_age_3m":{"total_number_of_other_articles":117452,"mean":8.4562988139736,"rank":59788,"this_scored_higher_than_pct":37,"this_scored_higher_than":43896,"rank_type":"exact","sample_size":117452,"percentile":37},"this_journal":{"total_number_of_other_articles":464,"mean":1.9929071274298,"rank":160,"this_scored_higher_than_pct":50,"this_scored_higher_than":236,"rank_type":"exact","sample_size":464,"percentile":50},"similar_age_this_journal_3m":{"total_number_of_other_articles":28,"mean":1.1916296296296,"rank":5,"this_scored_higher_than_pct":60,"this_scored_higher_than":17,"rank_type":"exact","sample_size":28,"percentile":60}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Researcher":1,"Student  > Ph. D. Student":1,"Other":3,"Student  > Master":1,"Professor":2,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":4,"Social Sciences":1,"Agricultural and Biological Sciences":1,"Biochemistry, Genetics and Molecular Biology":2,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"mendeley":{"US":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/inbraced\/status\/511433606695510016","license":"datasift","citation_ids":[2683620],"posted_on":"2014-09-15T08:37:28+00:00","author":{"name":"INBRACED","image":"https:\/\/pbs.twimg.com\/profile_images\/465146281568911360\/OW_wB0Bq_normal.jpeg","id_on_source":"inbraced","tweeter_id":"2483933496","geo":{"lt":null,"ln":null},"followers":46},"tweet_id":"511433606695510016"},{"url":"https:\/\/twitter.com\/Hakase_Taro\/status\/534686346514677761","license":"datasift","citation_ids":[2683620],"posted_on":"2014-11-18T12:35:33+00:00","author":{"name":"\u535a\u58eb\u30bf\u30ed\u30fc (HakaseTaro)","url":"http:\/\/www.STAT-ChildhoodCancer.JP","image":"https:\/\/pbs.twimg.com\/profile_images\/1174268438\/Hakase_Taro2_normal.jpg","description":"\u535a\u58eb\u30bf\u30ed\u30fc\u3067\u3059\u3002\nIt's a HakaseTaro.","id_on_source":"Hakase_Taro","tweeter_id":"219152053","geo":{"lt":null,"ln":null},"followers":37},"tweet_id":"534686346514677761"}],"facebook":[{"title":"Pharmacokinetics of the chimeric ... [Cancer Chemother Pharmacol. 2014] - PubMed - NCBI","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=635916813189825&id=561052004009640","license":"public","citation_ids":[2683620],"posted_on":"2014-09-15T12:18:56+00:00","summary":"Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastoma.\n\nCancer Chemother Pharmacol. 2014 Sep 12;","author":{"name":"INBRACED","url":"https:\/\/www.facebook.com\/561052004009640","facebook_wall_name":"INBRACED","image":"https:\/\/graph.facebook.com\/561052004009640\/picture","id_on_source":"561052004009640"}}]}}